Legal
First-in-class enterprise workflow platform for streamlining cell line development operations
The Garden State joins a long list of governments that have brought charges against opioid makers during an addiction crisis that claims the lives of 116 Americans per day.
The U.S. Environmental Protection Agency (EPA) has settled with two California companies for failing to provide required notifications for the handling of toxic chemicals.
Four former Genentech employees have been indicted by a federal grand jury for the alleged theft of company trade secrets in order to help a company set up in Taiwan develop drugs similar to those made by the Roche subsidiary.
As part of a plan to lower prescription drug prices for millions of Americans, President Donald Trump is set to announce a sweeping plan to overhaul how Medicare pays for medication.
Bloomberg Businessweek published a deep-dive into the life of the Shermans and the issues surrounding their death. “No one knows who did it, or why, but everyone has a theory,” the article’s subhead reads.
The Senate passed the bill on October 3 in a 98 to 1 vote. The House passed its version a week earlier in a vote of 393 to 8. The legislation includes provisions to promote research into new pain management drugs and expands access to substance abuse treatment for Medicaid patients.
Quark Venture Inc. has petitioned the British Columbia Supreme Court to overturn an unfavourable arbitration award concerning its decision to deny further investment to MSI Methylation Sciences, Inc. (“MSI”).
The U.S. Federal Trade Commission has cracked down on clinics that are making claims that certain stem cell therapies can treat a number of serious diseases such as Parkinson’s disease, autism, macular degeneration, cerebral palsy, multiple sclerosis, and heart attacks.
As more and more lawsuits are filed by state and local governments over the opioid epidemic, drugmakers are fighting back in court by demanding the allegations include specifics on how the companies are to blame.
PRESS RELEASES